Sox6 enhances erythroid differentiation in human erythroid progenitors

Blood

Volumn 117, Issue 13, 2011, Pages 3669-3679

  Cantù, Claudio ^a   Ierardi, Rossella ^b   Alborelli, Ilaria ^a   Fugazza, Cristina ^c   Cassinelli, Letizia ^a   Piconese, Silvia ^d   Bosè, Francesca ^e   Ottolenghi, Sergio ^a   Ferrari, Giuliana ^b,f   Ronchi, Antonella ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e Istituto Nazionale di Genetica Molecolare   (Italy)

^f VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR SOX6;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ERYTHROID CELL; ERYTHROPOIESIS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL;

EID: 79953693567     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-04-282350     Document Type: Article

References (50)

1. Wegner M. From head to toes: the multiple facets of Sox proteins. Nucleic Acids Res. 1999;27(6):1409-1420. (Pubitemid 29206280)
2. Schepers GE, Teasdale RD, Koopman P. Twenty pairs of Sox: extent, homology, and nomenclature of the mouse and human sox transcription factor gene families. Dev Cell. 2002;3(2):167-170.
3. Lefebvre V. The SoxD transcription factors-Sox5, Sox6, and Sox13-are key cell fate modulators. Int J Biochem Cell Biol. 2010;42(3):429-432.
4. Connor F, Wright E, Denny P, Koopman P, Ashworth A. The Sry-related HMG boxcontaining gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. Nucleic Acids Res. 1995;23(17):3365-3372.
5. Hamada-Kanazawa M, Ishikawa K, Ogawa D, et al. Suppression of Sox6 in P19 cells leads to failure of neuronal differentiation by retinoic acid and induces retinoic acid-dependent apoptosis. FEBS Lett. 2004;577(1-2):60-66. (Pubitemid 39452361)
6. Hamada-Kanazawa M, Ishikawa K, Nomoto K, et al. Sox6 overexpression causes cellular aggregation and the neuronal differentiation of P19 embryonic carcinoma cells in the absence of retinoic acid. FEBS Lett. 2004;560(1-3):192- 198. (Pubitemid 38264316)
7. Stolt CC, Schlierf A, Lommes P, et al. SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function. Dev Cell. 2006;11(5):697-709. (Pubitemid 44644960)
8. Ikeda T, Kamekura S, Mabuchi A, et al. The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. Arthritis Rheum. 2004;50(11):3561-3573. (Pubitemid 39488681)
9. Hagiwara N, Ma B, Ly A. Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H. Dev Dyn. 2005;234(2):301-311. (Pubitemid 41369139)
10. Hagiwara N, Klewer SE, Samson RA, et al. Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death. Proc Natl Acad Sci U S A. 2000;97(8):4180-4185. (Pubitemid 30226107)
11. Dumitriu B, Patrick MR, Petschek JP, et al. Sox6 cell-autonomously stimulates erythroid cell survival, proliferation, and terminal maturation and is thereby an important enhancer of definitive erythropoiesis during mouse development. Blood. 2006;108(4):1198-1207. (Pubitemid 44232015)
12. Dumitriu B, Bhattaram P, Dy P, et al. Sox6 is necessary for efficient erythropoiesis in adult mice under physiological and anemia-induced stress conditions. PLoS ONE. 2010;5(8):e12088.
13. Yi Z, Cohen-Barak O, Hagiwara N, et al. Sox6 directly silences epsilon globin expression in definitive erythropoiesis. PLoS Genet. 2006;2(2):e14.
14. Cohen-Barak O, Erickson DT, Badowski MS, et al. Stem cell transplantation demonstrates that Sox6 represses epsilon y globin expression in definitive erythropoiesis of adult mice. Exp Hematol. 2007;35(3):358-367.
15. Xu J, Sankaran VG, Ni M, et al. Transcriptional silencing of γ-globin by BCL11A involves long-range interactions and cooperation with SOX6. Genes Dev. 2010;24(8):783-798.
16. Tsiftsoglou AS, Vizirianakis IS, Strouboulis J. Erythropoiesis: model systems, molecular regulators, and developmental programs. IUBMB Life. 2009;61(8):800-830.
17. Palis J. Ontogeny of erythropoiesis. Curr Opin Hematol. 2008;15(3):155-161. (Pubitemid 351507565)
18. Cantor AB, Orkin SH. Transcriptional regulation of erythropoiesis: an affair involving multiple partners. Oncogene. 2002;21(21):3368-3376. (Pubitemid 34587709)
19. Perry C, Soreq H. Transcriptional regulation of erythropoiesis: fine tuning of combinatorial multidomain elements. Eur J Biochem. 2002;269(15):3607-3618. (Pubitemid 34989109)
20. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19(5):378-387. (Pubitemid 32900080)
21. Demaison C, Parsley K, Brouns G, et al. Highlevel transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther. 2002;13(7):803-813. (Pubitemid 34493974)
22. Francipane MG, Eterno V, Spina V, et al. Suppressor of cytokine signaling 3 sensitizes anaplastic thyroid cancer to standard chemotherapy. Cancer Res. 2009;69(15):6141-6148.
23. Follenzi A, Naldini L. HIV-based vectors: preparation and use. Methods Mol Med. 2002;69:259-274.
24. Migliaccio G, Di Pietro R, di Giacomo V, et al. In vitro mass production of human erythroid cells from the blood of normal donors and of thalassemic patients. Blood Cells Mol Dis. 2002;28(2):169-180. (Pubitemid 34743751)
25. Schreiber E, Matthias P, Muller MM, Schaffner W. Rapid detection of octamer binding proteins with "mini-extracts," prepared from a small number of cells. Nucleic Acids Res. 1989;17(15):6419.
26. Bosè F, Fugazza C, Casalgrandi M, et al. Functional interaction of CP2 with GATA-1 in the regulation of erythroid promoters. Mol Cell Biol. 2006;26(10):3942-3954. (Pubitemid 43726409)
27. Donaldson IJ, Göttgens B. TFBScluster web server for the identification of mammalian composite regulatory elements. Nucleic Acids Res. 2006;34(Web Server issue):W524-W528. (Pubitemid 44529825)
28. Cantù C, Grande V, Alborelli I, et al. A highly conserved SOX6 double binding site mediates SOX6 gene down-regulation in erythroid cells. Nucleic Acids Res. Prepublished on September 17, 2010, as DOI 10.1093/nar/gkq819.
29. (Now available as Nucleic Acids Res. 2011;39(2):486-501.)
30. Lefebvre V, Li P, de Crombrugghe B. A new long form of Sox5 (L-Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene. EMBO J. 1998;17(19):5718-5733. (Pubitemid 28445983)
31. Richmond TD, Chohan M, Barber DL. Turning cells red: signal transduction mediated by erythropoietin. Trends Cell Biol. 2005;15(3):146-155. 31.
32. Fried W. Erythropoietin and erythropoiesis. Exp Hematol. 2009;37(9):1007-1015.
33. Merchav S, Tatarsky I, Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor I. Br J Haematol. 1988;70(3):267-271. (Pubitemid 18265242)
34. Akahane K, Tojo A, Urabe A, Takaku F. Pure erythropoietic colony and burst formations in serum-free culture and their enhancement by insulin-like growth factor I. Exp Hematol. 1987;15(7):797-802. (Pubitemid 17151454)
35. Correa PN, Axelrad AA. Production of erythropoietic bursts by progenitor cells from adult human peripheral blood in an improved serum-free medium: role of insulinlike growth factor 1. Blood. 1991;78(11):2823-2833.
36. Emanuelli B, Peraldi P, Filloux C, et al. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem. 2000;275(21):15985-15991. (Pubitemid 30366903)
37. He B, You L, Uematsu K, et al. Cloning and characterization of a functional promoter of the human SOCS-3 gene. Biochem Biophys Res Commun. 2003;301(2):386-391. (Pubitemid 36279250)
38. Quentmeier H, MacLeod RAF, Zaborski M, Drexler HG. JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders. Leukemia. 2006;20(3):471-476. (Pubitemid 43291746)
39. Hookham MB, Elliott J, Suessmuth Y, et al. The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood. 2007;109(11):4924-4929. (Pubitemid 46827790)
40. Sasaki A, Yasukawa H, Suzuki A, et al. Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the Nterminal kinase inhibitory region as well as SH2 domain. genes cells. 1999;4(6):339-351. (Pubitemid 29359449)
41. Sasaki A, Yasukawa H, Shouda T, et al. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem. 2000;275(38):29338-29347. (Pubitemid 32043805)
42. Usenko T, Eskinazi D, Correa PN, et al. Overexpression of SOCS-2 and SOCS-3 genes reverses erythroid overgrowth and IGF-I hypersensitivity of primary polycythemia vera (PV) cells. Leuk Lymphoma. 2007;48(1):134-146. (Pubitemid 46978633)
43. Lakshmikuttyamma A, Pastural E, Takahashi N, et al. Bcr-Abl induces autocrine IGF-1 signaling. Oncogene. 2008;27(27):3831-3844. (Pubitemid 351862064)
44. Dey BR, Furlanetto RW, Nissley P. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor. Biochem Biophys Res Commun. 2000;278(1):38-43.
45. Sripichai O, Kiefer CM, Bhanu NV, et al. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming. Blood. 2009;114(11):2299-306.
46. Sankaran VG, Xu J, Orkin SH. Advances in the understanding of haemoglobin switching. Br J Haematol. 2010;149(2):181-194.
47. Rowley PT, Farley BA, LaBella S, Giuliano R, Leary JF. Single K562 human leukemia cells express and are inducible for both erythroid and megakaryocytic antigens. Int J Cell Cloning. 1992;10(4):232-240.
48. Fourouclas N, Li J, Gilby DC, et al. Methylation of the suppressor of cytokine signaling 3 gene (SOCS3) in myeloproliferative disorders. Haematologica. 2008;93(11):1635-1644.
49. Baker FA, Bellamy W, Tate WR, Bair WB III, Heaton R, List AF. Suppressor of cytokine signaling- 3 is overexpressed in erythroid precursors of myelodysplastic syndrome. Leukemia. 2006;20(9):1620-1621.
50. Majka M, Janowska-Wieczorek A, Ratajczak J, et al. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood. 2001;97(10):3075-3085.